VC-backed Entrada Therapeutics raises $181.5m for IPO
Entrada Therapeutics, a biotech company, has raised $181.5 million for its IPO after pricing its over 9 million shares at $20 per share.
Entrada Therapeutics, a biotech company, has raised $181.5 million for its IPO after pricing its over 9 million shares at $20 per share.
Copyright PEI Media
Not for publication, email or dissemination